Dong-A crowned with top prescription drug company

Published: 2011-03-15 06:59:00

Updated: 2011-03-15 06:59:00

Dong-A Pharmaceutical posted the highest revenue in Korea’s prescription drug market last year, with 471.6 billion won in terms of EDI claims, according to the Health Insurance Review and Assessment Service.

Thanks to robust sales of a homegrown drug Stillen and other flagship products, Dong-A...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK